Purdue Pharma’s Avrio Health subsidiary is giving 340B covered entities refunds for overcharges on Betasept antiseptic surgical scrub for purchases spanning 16 years—from Q2 2005 through Q2 2021. That period covers more than half of the 340B program’s existence.
During a speech yesterday at the 340B Coalition summer conference, 340B Health President and CEO Maureen Testoni observed that the U.S. Health Resources and Services Administration (HRSA) already had posted 22 manufacturer notices of refunds for 340B overcharges this year, compared with 17 such notices during their entirety of 2021.
Purdue Pharma’s Avrio Health subsidiary is giving 340B covered entities refunds for overcharges on Betasept antiseptic surgical scrub for purchases spanning 16 years—from Q2 2005 through Q2 2021.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
